Burles Johnson and Roy Elias discuss a composite B cell/CD8 T cell biomarker analysis, examining whether the B8T gene signature improves prognostic and predictive value beyond ctDNA status in post-cystectomy high-risk urothelial carcinoma from IMvigor010.
|